---

Medlab Clinical CEO Dr. Sean Hall announces plans for expansion into Europe

---

Medlab Open Day - 5th December 2018

---

Medicinal Cannabis Milestone

Ross Greenwood speaks to Medlab CEO Sean Hall about the first successful shipment of cannabis-based medicine, NanaBis. (NanaBis^TM is an investigative new product containing 1:1 ratios of Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), delivery in a sub micron spray to the oro-buccal membrane.)

---

ImmunoZyme^TM

ImmunoZyme^TM is a unique combination of beta-glucans and digestive enzymes, derived from Maitake and Reishi mushrooms and plants, designed to support immune system function and digestive health.

• Optimise beta-glucan availability
• Enhance immune system function
• Support digestion of dietary proteins, carbohydrates and lipids
• Assist in the management of general well-being

More Information